TESARO Announces Addition of ZEJULA to Cancer Drugs Fund in UK Inclusion in the Cancer Drugs Fund will give more women in England and Wales with recurrent, platinum-sensitive ovarian cancer access to ZEJULA via a managed access arrangementZEJULA was launched in...